The impact of migraine prevention on daily activities: a longitudinal and responder analysis from three topiramate placebo-controlled clinical trials-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The impact of migraine prevention on daily activities: a longitudinal and responder analysis from three topiramate placebo-controlled clinical trials

Published:2007-10-04 Issue:1 Volume:5 Page:
ISSN:1477-7525
Container-title:Health and Quality of Life Outcomes
language:en
Short-container-title:Health Qual Life Outcomes

Author:

Dahlöf Carl,Loder Elizabeth,Diamond Merle,Rupnow Marcia,Papadopoulos George,Mao Lian

Publisher

Springer Science and Business Media LLC

Subject

Public Health, Environmental and Occupational Health,General Medicine

Link

http://link.springer.com/content/pdf/10.1186/1477-7525-5-56.pdf

Reference14 articles.

1. Silberstein S, Diamond S, Loder E, Reed ML, Lipton RB: Prevalence of migraine sufferers who are candidates for preventive therapy: results from the American Migraine Prevalence and Prevention (AMPP) Study. Headache 2005, 45: 770–771. 10.1111/j.1526-4610.2005.00250.x

2. Lipton RB, Bigal ME, Diamond M, Freitag F, Reed ML, Stewart WF, AMPP Advisory Group: Migraine prevalence, disease burden, and the need for preventive therapy. Neurology 2007, 68: 343–349. 10.1212/01.wnl.0000252808.97649.21

3. Silberstein SD, Neto W, Schmitt J, Jacobs D, MIGR-001 Study Group: Topiramate in migraine prevention: results of a large controlled trial. Arch Neurol 2004, 61: 490–495. 10.1001/archneur.61.4.490

4. Brandes JL, Saper JR, Diamond M, Couch JR, Lewis DW, Schmitt J, Neto W, Schwabe S, Jacobs D, MIGR-002 Study Group: Topiramate for migraine prevention: a randomized controlled trial. JAMA 2004, 291: 965–973. 10.1001/jama.291.8.965

5. Diener HC, Tfelt-Hansen P, Dahlof C, Lainez MJ, Sandrini G, Wang SJ, Neto W, Vijapurkar U, Doyle A, Jacobs D, MIGR-003 Study Group: Topiramate in migraine prophylaxis – results from a placebo-controlled trial with propranolol as an active control. J Neurol 2004, 251: 943–950. 10.1007/s00415-004-0464-6

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Once‐daily oral atogepant for the long‐term preventive treatment of migraine: Findings from a multicenter, randomized, open‐label, phase 3 trial;Headache: The Journal of Head and Face Pain;2023-01

2. The association between melatonin and episodic migraine: A pilot network meta‐analysis of randomized controlled trials to compare the prophylactic effects with exogenous melatonin supplementation and pharmacotherapy;Journal of Pineal Research;2020-05-23

3. Two randomized migraine studies of galcanezumab;Neurology;2019-07-03

4. Measures of Functioning in Patients With Episodic Migraine: Findings From a Double-Blind, Randomized, Placebo-Controlled Phase 2b Trial With Galcanezumab;Headache: The Journal of Head and Face Pain;2018-08-14

5. Health-related quality of life with hereditary angioedema following prophylaxis with subcutaneous C1-inhibitor with recombinant hyaluronidase;Allergy and Asthma Proceedings;2017-03-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3